---
title: "Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Humanistic burden and health-related quality of life"
description: "Formulary evidence on Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Humanistic burden and health-related quality of life. Topics: Child health-related quality of life: CHQ-PF50 in the US Natural History Study, Child quality of life and family functioning: PedsQL in 23 families in Poland, Caregiver health-related quality of life: SF-36v2 in the US Natural History Study, Caregiver health utility: EQ-5D-5L and CarerQol-7D in 37 UK caregivers, and 7 further topics. 11 evidence topics quoted from 17 sources."
canonical: "https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description/humanistic-burden-and-health-related-quality-of-life"
published: "2026-11-15T20:23:41-05:00"
modified: "2026-11-15T20:23:41-05:00"
---

# Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Humanistic burden and health-related quality of life

<a id="heading-2.2.1.8.1"></a>

## 2.2.1.8.1 Humanistic Burden and Health-related Quality of Life

<a id="topic-2.2.1.8.1-1"></a>

### Child health-related quality of life: CHQ-PF50 in the US Natural History Study

> “More than 200 participants from 5 to 18 years of age with classic RTT finished their 2-year follow-up at the time of analysis.”
> “Each CHQ-PF50 domain score was compared with the standard US girl score reported in the QOL manual. All scores other than those for Behavior and Family Cohesion were significantly lower than those from standard US girls.”
> “Severe clinical impairment was highly associated with poor physical QOL, but worse motor function and earlier age at onset of RTT stereotypies were associated with better psychosocial QOL; conversely, better motor function was associated with poorer psychosocial QOL.”

Source: [Lane et al. (2011)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3233210/)

<a id="topic-2.2.1.8.1-2"></a>

### Child quality of life and family functioning: PedsQL in 23 families in Poland

> “We included 23 parents of children with RTT. In this study, we used the PedsQL™ Family Impact Module, the Pediatric Quality of Life Inventory 4.0 generic core scales (PedsQL™ 4.0), and an author-designed questionnaire to assess QoL and family functioning.”
> “QOL in children with RTT, as perceived by their parents, is reduced. RTT has a significant negative correlation with family functioning.”

Source: [Rozensztrauch et al. (2021)](https://pmc.ncbi.nlm.nih.gov/articles/PMC8111277/)

<a id="topic-2.2.1.8.1-3"></a>

### Caregiver health-related quality of life: SF-36v2 in the US Natural History Study

> “Caretaker physical component scores (PCS) were higher than mental component scores (MCS): 52.8 (9.7) versus 44.5 (12.1). No differences were noted between the baseline and 5-year follow-up. In univariate analyses, disease severity was associated with poorer PCS (p=0.006) and improved MCS (p=0.003). Feeding problems were associated with poorer PCS (p=0.007) and poorer MCS (p=0.018).”
> “The PCS and MCS scores of 35-44 year old females from the United States general population are 51.6 (8.6) and 47.8 (10.4) respectively”
> “For caretakers of those with RTT, this demonstrates similarity of PCS to the general population, but lower MCS scores at 44.6 (12.1).”

Source: [Killian et al. (2016)](https://pmc.ncbi.nlm.nih.gov/articles/PMC4899118/)

<a id="topic-2.2.1.8.1-4"></a>

### Caregiver health utility: EQ-5D-5L and CarerQol-7D in 37 UK caregivers

> “A multi-method study was conducted between June-August 2025 with N=37 caregivers of individuals with RTT in the UK.”
> “The mean EQ-5D-5L score of caregivers was 0.62 (SD=0.25), with 49% and 38% reporting moderate-to-severe problems with anxiety/depression and pain/discomfort, respectively. Mean CarerQoL-7D utility was 60.76 (SD=18.11) with impacts on daily activities and finances being most reported.”
> “Worsening physical health (95%) due to ongoing fatigue, sleep disturbance, and the physical demands of caregiving were also commonly reported. All participants also described experiencing negative psychological impacts such as anxiety, depression and a sense of grief for the life they once envisioned for themselves and their child.”

Source: [Pimprikar et al. (2026)](https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-2026/poster-session-2-4/the-impact-of-caring-for-their-children-with-rett-syndrome-a-multi-method-study)

<a id="topic-2.2.1.8.1-5"></a>

### Parenting stress: Parenting Stress Index in 35 caregivers

> “A majority (60%) of parents reported stress in the clinical range on at least one subscale of the Parenting Stress Index – Short Form. Seizures and uncertainty about their daughter’s gastrointestinal pain experience were significantly associated with higher levels of parenting stress.”

Source: [Byiers et al. (2014)](https://pmc.ncbi.nlm.nih.gov/articles/PMC3992319/)

<a id="topic-2.2.1.8.1-6"></a>

### Burden of illness: disorder-specific caregiver survey of 756 caregivers in the USA, Europe, and Australia

> “The questionnaire was administered anonymously online to an international sample of 756 caregivers (predominantly parents) of girls and women with RTT.”
> “There was variability in reported frequency of problems, with the most prevalent, severe and impactful being those related to the core features of RTT (i.e., communication and fine and gross motor impairments).”
> “ANOVAs showed that many problems had disproportionately greater impact than severity, either on affected individuals (e.g., hand stereotypies) or their caregivers (e.g., sleep difficulties, seizures, pain, and behavioral abnormalities).”
> “There was a wide range of frequency of problems, from ~ 35% for hyperventilation to 99% for impairments in self-care activities of daily living. Core features or impairments were present in 70–98% of affected individuals, while other problems were more variable.”

Source: [Kaufmann et al. (2024)](https://pmc.ncbi.nlm.nih.gov/articles/PMC11323357/)

<a id="topic-2.2.1.8.1-7"></a>

### Caregiver priorities: top concerns in the US Natural History Study, 925 caregivers

> “Caregivers of participants enrolled in the US Natural History Study of RTT and RTT-related disorders (n = 925) were asked to identify the top 3 concerning problems impacting the affected participant.”
> “The top caregiver concerns for classic RTT were effective communication, seizures, walking/balance issues, lack of hand use, and constipation.”

Source: [Neul et al. (2023c)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10571464/)

<a id="topic-2.2.1.8.1-8"></a>

### Symptoms with severe impact on quality of life: TSHA-102 sponsor caregiver survey, 323 caregivers in four countries

> “This work was funded by Taysha Gene Therapies, Inc., in accordance with Good Publications Practice.”
> “In total, 323 caregivers from the USA (n = 85), the UK (n = 115), Canada (n = 45), and Israel (n = 78) participated.”
> “Symptoms that were most commonly reported as having a severe impact on quality of life (QoL) included loss of speech (81%, n = 261), loss of purposeful hand use (80%, n = 259), loss of independent walking (61%, n = 198), loss of mobility (59%, n = 189), and involuntary hand movements (57%, n = 184).”
> “Over three-quarters of respondents (76%, n = 245) indicated that ≥ 1 new or newly challenging symptom had emerged in the 2 years prior to the survey, the most common of which was the loss of mobility, reported by 63% of caregivers.”

Source: [Ben-Zeev et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13615242/)

<a id="topic-2.2.1.8.1-9"></a>

### Impact on daily activities: caregiver diaries in eight European countries

> “Sixty caregivers across eight countries completed five-day diaries, and thirty participated in in-depth interviews.”
> “Daily activities were heavily affected, with symptoms impacting 59% of activities for children, 61% for adolescents, and 38% for adults.”

Source: [Pulles et al. (2026)](https://pmc.ncbi.nlm.nih.gov/articles/PMC13721293/)

<a id="topic-2.2.1.8.1-10"></a>

### Care coordination and caregiver stress: parent survey in Italy

> “The data refers to 52 patients, all females, with a median age of 15 years at the time of the survey.”
> “The study shows that caregivers of RS patients take over most obligations and burdens by increasing their perceived level of stress. For the majority of patients, the most frequent complications were not followed by the reference subspecialist, with the only exception of epilepsy.”

Source: [Cherchi et al. (2023)](https://pmc.ncbi.nlm.nih.gov/articles/PMC10605630/)

<a id="topic-2.2.1.8.1-11"></a>

### Patient health utility: utility weights derived from the Rett Syndrome Behaviour Questionnaire

> “This study was conducted to develop utility-based scoring weights from the 45-item Rett Syndrome Behaviour Questionnaire (RSBQ), a disease-specific measure.”
> “Disutility weights for each level of each attribute were calculated using the DCE model coefficients rescaled against the worst and best health states, which ranged from 0.22 to 0.87.”

Source: [Skrobanski et al. (2025)](https://www.ispor.org/heor-resources/presentations-database/presentation-cti/ispor-europe-2025/poster-session-5-2/the-estimation-of-utility-weights-from-the-rett-syndrome-behavior-questionnaire)

Additional sources: [Epstein et al. (2016)](https://pubmed.ncbi.nlm.nih.gov/26686505/); [Strugnell et al. (2020)](https://pubmed.ncbi.nlm.nih.gov/31074665/); [Downs et al. (2019)](https://pubmed.ncbi.nlm.nih.gov/30460513/); [Corchón et al. (2018)](https://pubmed.ncbi.nlm.nih.gov/30220073/); [McGraw et al. (2023)](https://pubmed.ncbi.nlm.nih.gov/37161302/); [Wong et al. (2018)](https://pubmed.ncbi.nlm.nih.gov/29941161/)

## Related pages
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Terms and abbreviations](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/terms-and-abbreviations.md)
- [Lonimecgene renparvovec (TSHA-102): Rett syndrome](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/executive-summary.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Product information and disease description](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/product-information-and-disease-description.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Clinical evidence](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/clinical-evidence.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: Economic information and modeling report](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/economics.md)
- [Lonimecgene renparvovec (TSHA-102) in Rett syndrome: References](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references) · [Markdown](https://www.evicenter.com/drugs/lonimecgene-renparvovec--rett-syndrome/references.md)
